Kangpu Biopharmaceuticals — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

A Chinese biopharma firm engineering novel antibody therapies for autoimmune and oncological diseases.

Autoimmune DiseasesOncologyInflammatory Diseases

Employs an integrated antibody discovery and engineering platform to generate high-affinity, humanized therapeutic antibodies.

Large market potential for novel biologics in autoimmune and oncology, especially in the growing Chinese healthcare market.

Technical and regulatory challenges in biologics development, including complex manufacturing and potential immunogenicity issues.

Operates in a highly competitive field with many established biologic drugs and numerous biotechs developing similar antibody therapies.